Brief: Sosei Group subsidiary Heptares enters strategic collaboration with PeptiDream

PeptiDream

29/06/2017 08:17

June 29(Reuters) - Sosei Group Corp  4565.T  
     
    * Says its unit Heptares Therapeutics and PeptiDream Inc 
 4587.T , a public Tokyo-based biopharmaceutical company, have 
entered into a strategic collaboration to discover, develop and 
commercialise novel therapeutics targeting an undisclosed G 
protein-coupled receptor (GPCR) with an important role in 
inflammatory diseases 
 
     
     
    Source text in Japanese:https://goo.gl/JfvDjh 
    Further company coverage: 4565.T  4587.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))